-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=952D167995BFFB605F278908E8DF95C4
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=ADBA8F4DEA4E5EF37F88D25A9BF292ED
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=DA4816C5111BDCBC1E93B29DCB64D6DA
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=E92854CC8B885E1590A60A381F38BC20
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=4487545C3B0F2A9161A2A912940C73DC
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=37BA9F4C011E1890748A6A47878493D1
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=BFC3FF62244D4F0B45E7DA3149CD2489
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=C7C4A882388481A53B2748E44A5A2549
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=8151426E418DC21FF60D939D1A84ECDC
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
digital.ahrq.gov/ahrq-funded-projects/research-agenda-patient-centered-medical-home/annual-summary/2010
January 01, 2010 - Strategic Goal: Not Applicable
Business Goal: Synthesis and Dissemination
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=88FF0D214F378A4DA479A670B770290D
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
hcup-us.ahrq.gov/toolssoftware/ccs_svcsproc/ccscpt_license.jsp;jsessionid=7D457B3B0DC0FD5DD88D6C0AC204325A
January 01, 2019 - Applicable FARS/DFARS Restrictions Apply to Government Use
Disclaimer of Warranties and Liabilities
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation-september-2015
September 07, 2015 - In addition, no new studies that would be applicable to the current U.S. population evaluated oral iron … No good- or fair-quality studies that would be applicable to the current U.S. population 2 evaluated … There was 1 older poor-quality study on the benefits and harms of treatment, but it was not applicable … Since 2006, the USPSTF has updated its methodology to better identify evidence that would be most applicable … Therefore, the USPSTF determined that the currently available and applicable evidence on screening for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
July 01, 2012 - to specific versions of the test, selected
study methods or types, or populations most likely to be applicable … can be more difficult to accomplish when parties differ with respect to the value they place on
less applicable … Decisions about the intended approach to the use of literature that is not directly
applicable need … appropriate to include and comment on this material, clearly
documenting how it may not be directly applicable … Restricting the review to
techologies available in the United States, and therefore most applicable,
-
effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria.ppt
January 01, 2000 - “distortion of the estimate of effect that comes from how studies are selected” and may affect how applicable … studies of twin pregnancies in a review of preterm labor management for low-risk women may not provide applicable … important when there has been a change in policy, practice, or formulation that makes older studies less applicable … In what setting would the results be applicable?
-
psnet.ahrq.gov/web-mm/lost-sign-out-and-documentation
January 31, 2011 - intravenous fluid infusions
Name and contact of substitute decision maker
Tracheostomy care (if applicable … )
Antibiotic use/duration/discontinuation dates
Date of extubation (if applicable)
Isolation … status
Suction requirements (if applicable)
References
1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_clinician.pdf
June 01, 2016 - difference NA ���
95% BCI = 95-percent Bayesian credible interval; IH = infantile hemangioma; NA = not applicable … It is unclear if findings are applicable to children
of specific ages, with a particular stage of IH … It is unclear if
the findings from these studies are applicable to the current
standard of care for
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction-to-user-guide-overview.pptx
January 01, 2013 - Results of randomized controlled trials are not always applicable to real-world settings. … Researcher and stakeholder collaborations on protocol design allow relevant, applicable results that … Collaborations between researchers and stakeholders should be formed so the outputs of research are relevant, applicable
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - • If we found new evidence that rendered the CER conclusion out of date or no longer
applicable, … 55
Author year
Study name
(if applicable)
Study
design
Subjects
Treatment groups … 0.1 (1.5), 0.3, 3.1 vs. 0.5(2.3), 1.0, 3.4; p=0.03
56
Author year
Study name
(if applicable … 17;two,
1hour sessions per
6 weeks Urinary loss
57
Author year
Study name
(if applicable … Control
59
Author year
Study name
(if applicable)
Study
design
Subjects